BPG is committed to discovery and dissemination of knowledge
Cited by in CrossRef
For: Parfieniuk A, Flisiak R. Role of cannabinoids in chronic liver diseases. World J Gastroenterol 2008; 14(40): 6109-6114 [PMID: 18985799 DOI: 10.3748/wjg.14.6109]
URL: https://www.wjgnet.com/1007-9327/full/v14/i40/6109.htm
Number Citing Articles
1
Joseph B. Miller, Mark Walsh, Pankaj A. Patel, Michael Rogan, Cliff Arnold, Megan Maloney, Michael Donnino. Pediatric Cannabinoid HyperemesisPediatric Emergency Care 2010; 26(12): 919 doi: 10.1097/PEC.0b013e3181fe9189
2
Anna Maria Malfitano, Elena Ciaglia, Giuseppina Gangemi, Patrizia Gazzerro, Chiara Laezza, Maurizio Bifulco. Update on the endocannabinoid system as an anticancer targetExpert Opinion on Therapeutic Targets 2011; 15(3): 297 doi: 10.1517/14728222.2011.553606
3
Rebekah Nash, Eric Golden, Mary Amanda Dew, Andrea F. DiMartini. Psychosocial Care of End-Stage Organ Disease and Transplant Patients2019; : 147 doi: 10.1007/978-3-319-94914-7_12
4
Botros Shenoda, Joseph Boselli. Vascular syndromes in liver cirrhosisClinical Journal of Gastroenterology 2019; 12(5): 387 doi: 10.1007/s12328-019-00956-0
5
Carmen M. Mitchell, Omar El Jordi, Bryan K. Yamamoto. Role of Inflammation in Environmental NeurotoxicityAdvances in Neurotoxicology 2019; 3: 133 doi: 10.1016/bs.ant.2018.10.006
6
Siwei Tan, Huiling Liu, Bilun Ke, Jie Jiang, Bin Wu. The peripheral CB1 receptor antagonist JD5037 attenuates liver fibrosis via a CB1 receptor/β‐arrestin1/Akt pathwayBritish Journal of Pharmacology 2020; 177(12): 2830 doi: 10.1111/bph.15010
7
Daniel Fuster, Xavier García-Calvo, Ferran Bolao, Paola Zuluaga, Gemma Rocamora, Anna Hernández-Rubio, Arantza Sanvisens, Jordi Tor, Robert Muga. Cannabis use is associated with monocyte activation (sCD163) in patients admitted for alcohol use disorder treatmentDrug and Alcohol Dependence 2020; 216: 108231 doi: 10.1016/j.drugalcdep.2020.108231
8
Pratima Dibba, Andrew Li, George Cholankeril, Umair Iqbal, Chiranjeevi Gadiparthi, Muhammad Khan, Donghee Kim, Aijaz Ahmed. The Role of Cannabinoids in the Setting of CirrhosisMedicines 2018; 5(2): 52 doi: 10.3390/medicines5020052
9
Yu-Jin Kwon, Ji-Hye Kim, Dong-Hyuk Jung. Association Between Nonalcoholic Fatty Liver Disease and Intraocular Pressure in Korean AdultsJournal of Glaucoma 2018; 27(12): 1099 doi: 10.1097/IJG.0000000000001036
10
Hemant Goyal, M. Rubayat Rahman, Abhilash Perisetti, Nihar Shah, Rajiv Chhabra. Cannabis in liver disorders: a friend or a foe?European Journal of Gastroenterology & Hepatology 2018; 30(11): 1283 doi: 10.1097/MEG.0000000000001256
11
Munechika Enjoji, Motoyuki Kohjima, Kazuhiro Kotoh, Makoto Nakamuta. Metabolic Disorders and Steatosis in Patients with Chronic Hepatitis C: Metabolic Strategies for Antiviral TreatmentsInternational Journal of Hepatology 2012; 2012: 1 doi: 10.1155/2012/264017
12
Cannabis2016; : 229 doi: 10.1201/9781315367583-20
13
Tina M. St. John. Integrative Medicine2018; : 198 doi: 10.1016/B978-0-323-35868-2.00021-9
14
P. P. Basu, M. M. Aloysius, N. J. Shah, R. S. Brown Jr. Review article: the endocannabinoid system in liver disease, a potential therapeutic targetAlimentary Pharmacology & Therapeutics 2014; 39(8): 790 doi: 10.1111/apt.12673
15
Part I: Current Legislation, Scientific Literature Review, and Nursing ImplicationsJournal of Nursing Regulation 2018; 9(2): S6 doi: 10.1016/S2155-8256(18)30083-8
16
Ismail Maulood. Hemodynamic ,thyroid and immunomodulater effects of cannabinoid in rats.Journal of Zankoy Sulaimani - Part A 2016; 18(2): 71 doi: 10.17656/jzs.10505
17
Hedyeh Ebrahimi, Mohammadreza Naderian, Amir Ali Sohrabpour. New Concepts on Reversibility and Targeting of Liver Fibrosis; A Review ArticleMiddle East Journal of Digestive Diseases 2018; 10(3): 133 doi: 10.15171/mejdd.2018.103
18
David van der Poorten, Mahsa Shahidi, Enoch Tay, Jayshree Sesha, Kayla Tran, Duncan McLeod, Jane S. Milliken, Vikki Ho, Lionel W. Hebbard, Mark W. Douglas, Jacob George, Jean-Pierre Vartanian. Hepatitis C Virus Induces the Cannabinoid Receptor 1PLoS ONE 2010; 5(9): e12841 doi: 10.1371/journal.pone.0012841
19
Li-Jie Sun, Jian-Wu Yu, Lin Wan, Xiao-Yu Zhang, Yu-Guang Shi, Mo-Yang Chen. Endocannabinoid system activation contributes to glucose metabolism disorders of hepatocytes and promotes hepatitis C virus replicationInternational Journal of Infectious Diseases 2014; 23: 75 doi: 10.1016/j.ijid.2013.12.017
20
Eleonora Patsenker, Matthias Stoll, Gunda Millonig, Abbas Agaimy, Till Wissniowski, Vreni Schneider, Sebastian Mueller, Rudolf Brenneisen, Helmut K. Seitz, Matthias Ocker, Felix Stickel. Cannabinoid Receptor Type I Modulates Alcohol-Induced Liver FibrosisMolecular Medicine 2011; 17(11-12): 1285 doi: 10.2119/molmed.2011.00149
21
Susanne Oesch, Jürg Gertsch. Cannabinoid receptor ligands as potential anticancer agents — high hopes for new therapies?Journal of Pharmacy and Pharmacology 2010; 61(7): 839 doi: 10.1211/jpp.61.07.0002
22
Kathleen A. Russell. Caring for Patients Using Medical MarijuanaJournal of Nursing Regulation 2019; 10(3): 47 doi: 10.1016/S2155-8256(19)30148-6
23
Eric Mensah, Reza Tabrizchi, Noriko Daneshtalab. Pharmacognosy and Effects of Cannabinoids in the Vascular SystemACS Pharmacology & Translational Science 2022; 5(11): 1034 doi: 10.1021/acsptsci.2c00141
24
Yan Wei, Xiao-li Kang, Xu Wang. The peripheral cannabinoid receptor 1 antagonist VD60 efficiently inhibits carbon tetrachloride-intoxicated hepatic fibrosis progressionExperimental Biology and Medicine 2014; 239(2): 183 doi: 10.1177/1535370213514922
25
Julie Zhu, Kevork M Peltekian. Cannabis and the liver: Things you wanted to know but were afraid to askCanadian Liver Journal 2019; 2(3): 51 doi: 10.3138/canlivj.2018-0023
26
Yosefa Avraham, Johnny Amer, Sarit Doron, Lina Abu-Tair, Mahmud Mahamid, Areej Khatib, Elliot M. Berry, Rifaat Safadi. The direct profibrotic and indirect immune antifibrotic balance of blocking the cannabinoid 2 receptorAmerican Journal of Physiology-Gastrointestinal and Liver Physiology 2012; 302(12): G1364 doi: 10.1152/ajpgi.00191.2011
27
Nazar Pryimak, Mariia Zaiachuk, Olga Kovalchuk, Igor Kovalchuk. The Potential Use of Cannabis in Tissue FibrosisFrontiers in Cell and Developmental Biology 2021; 9 doi: 10.3389/fcell.2021.715380
28
Ralph-Sydney Mboumba Bouassa, Giada Sebastiani, Vincenzo Di Marzo, Mohammad-Ali Jenabian, Cecilia T. Costiniuk. Cannabinoids and Chronic Liver DiseasesInternational Journal of Molecular Sciences 2022; 23(16): 9423 doi: 10.3390/ijms23169423
29
Wei Chen, Zhenhua Chen, Nina Xue, Zhibing Zheng, Song Li, LiLi Wang. Effects of CB1 receptor blockade on monosodium glutamate induced hypometabolic and hypothalamic obesity in ratsNaunyn-Schmiedeberg's Archives of Pharmacology 2013; 386(8): 721 doi: 10.1007/s00210-013-0875-y
30
Laurence Brunet, Erica E. M. Moodie, Kathleen Rollet, Curtis Cooper, Sharon Walmsley, Martin Potter, Marina B. Klein. Marijuana Smoking Does Not Accelerate Progression of Liver Disease in HIV–Hepatitis C Coinfection: A Longitudinal Cohort AnalysisClinical Infectious Diseases 2013; 57(5): 663 doi: 10.1093/cid/cit378
31
Cecilia J. Sorensen, Kristen DeSanto, Laura Borgelt, Kristina T. Phillips, Andrew A. Monte. Cannabinoid Hyperemesis Syndrome: Diagnosis, Pathophysiology, and Treatment—a Systematic ReviewJournal of Medical Toxicology 2017; 13(1): 71 doi: 10.1007/s13181-016-0595-z
32
Part I: Current Legislation, Scientific Literature Review, and Nursing ImplicationsJournal of Nursing Regulation 2018; 9(2): S6 doi: 10.1016/S2155-8256(18)30083-8
33
Puneet Puri, Arun J. Sanyal. Zakim and Boyer's Hepatology2012; : 941 doi: 10.1016/B978-1-4377-0881-3.00053-X
34
Melissa A. Sheiko, Hugo R. Rosen. Hepatitis C Virus II2016; : 79 doi: 10.1007/978-4-431-56101-9_3
35
Eleonora Patsenker, Philip Sachse, Andrea Chicca, María Gachet, Vreni Schneider, Johan Mattsson, Christian Lanz, Mathias Worni, Andrea de Gottardi, Mariam Semmo, Jochen Hampe, Clemens Schafmayer, Rudolf Brenneisen, Jürg Gertsch, Felix Stickel, Nasser Semmo. Elevated Levels of Endocannabinoids in Chronic Hepatitis C May Modulate Cellular Immune Response and Hepatic Stellate Cell ActivationInternational Journal of Molecular Sciences 2015; 16(12): 7057 doi: 10.3390/ijms16047057
36
Samar Rezq, Reham Hassan, Mona F. Mahmoud. Rimonabant ameliorates hepatic ischemia/reperfusion injury in rats: Involvement of autophagy via modulating ERK- and PI3K/AKT-mTOR pathwaysInternational Immunopharmacology 2021; 100: 108140 doi: 10.1016/j.intimp.2021.108140
37
Ahmed ElTelbany, George Khoudari, Yasser Al-Khadra, Arthur McCullough, Naim Alkhouri. Lower Rates of Hepatocellular Carcinoma Observed Among Cannabis Users: A Population-Based StudyCureus 2022;  doi: 10.7759/cureus.24576
38
Massimo Pinzani, Jose Macias-Barragan. Update on the pathophysiology of liver fibrosisExpert Review of Gastroenterology & Hepatology 2010; 4(4): 459 doi: 10.1586/egh.10.47
39
Madeline Manning Meurer, Kalyan Chakrala, Dinesh Gowda, Charles Burns, Randall Kelly, Natalia Schlabritz-Loutsevitch. A Case of Cannabinoid Hyperemesis Syndrome with Heliobacter Pylori and Preeclampsia during PregnancySubstance Abuse 2018; 39(1): 9 doi: 10.1080/08897077.2017.1356790
40
Sara Manti, Lucia Marseglia, Gabriella D Angelo, Martina Filippelli, Caterina Cuppari, Eloisa Gitto, Claudio Romano, Teresa Arrigo, Carmelo Salpietro. Portal Hypertension as Immune Mediate DiseaseHepatitis Monthly 2014; 14(5) doi: 10.5812/hepatmon.18625
41
Appendix C: References (Part I)Journal of Nursing Regulation 2018; 9(2): S52 doi: 10.1016/S2155-8256(18)30100-5
42
Tina M. St. John. Integrative Medicine2012; : 171 doi: 10.1016/B978-1-4377-1793-8.00019-4
43
Ayman Alzu’bi, Mazhar Salim Al Zoubi, Bahaa Al-Trad, Manal Isam AbuAlArjah, Malek Shehab, Hiba Alzoubi, Dima Albals, Gamal T. Abdelhady, Waseem El-Huneidi. Acute Hepatic Injury Associated with Acute Administration of Synthetic Cannabinoid XLR-11 in Mouse Animal ModelToxics 2022; 10(11): 668 doi: 10.3390/toxics10110668
44
P.N. Soares, R.A. Miranda, T.C. Peixoto, F.A.H. Caramez, D.S. Guarda, A.C. Manhães, E. de Oliveira, E.G. de Moura, P.C. Lisboa. Cigarette smoke during lactation in rat female progeny: Late effects on endocannabinoid and dopaminergic systemsLife Sciences 2019; 232: 116575 doi: 10.1016/j.lfs.2019.116575
45
Leontina-Elena Filipiuc, Raluca Ştefănescu, Carmen Solcan, Mitică Ciorpac, Andrei Szilagyi, Dana Cojocaru, Gabriela Dumitrita Stanciu, Ioana Creangă, Cătălin-Cezar Caratașu, Daniela-Carmen Ababei, Roxana-Elena Gavrila, Andrei-Daniel Timofte, Silviu-Iulian Filipiuc, Veronica Bild. Acute Toxicity and Pharmacokinetic Profile of an EU-GMP-Certified Cannabis sativa L. in RodentsPharmaceuticals 2023; 16(5): 694 doi: 10.3390/ph16050694
46
Ayman Alzu’bi, Fatimah Almahasneh, Ramada Khasawneh, Ejlal Abu-El-Rub, Worood Bani Baker, Raed M. Al-Zoubi. The synthetic cannabinoids menace: a review of health risks and toxicityEuropean Journal of Medical Research 2024; 29(1) doi: 10.1186/s40001-023-01443-6